HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brigitte Dreno Selected Research

Immunotherapy

11/2023The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus.
9/2023Long-term strategies for management of advanced basal cell carcinoma with hedgehog inhibitors.
6/2023Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
4/2023Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
1/2023Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective cohort study (MelBase).
9/2021Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases.
4/2021Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
1/2018Exogenous human herpesvirus 6 reinfection after tumor-infiltrating T-lymphocyte therapy.
12/2017Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.
4/2011Is antigen specificity the key to efficient adoptive T-cell therapy?
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brigitte Dreno Research Topics

Disease

54Melanoma (Melanoma, Malignant)
10/2023 - 03/2002
27Acne Vulgaris
01/2024 - 03/2003
24Neoplasms (Cancer)
11/2023 - 03/2002
7Cicatrix (Scar)
01/2024 - 01/2007
6Disease Progression
01/2022 - 06/2011
5Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2021 - 01/2007
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2023 - 06/2011
4Inflammation (Inflammations)
01/2022 - 06/2007
4Basal Cell Carcinoma (Rodent Ulcer)
01/2022 - 08/2014
4Exanthema (Rash)
01/2016 - 06/2011
4Diarrhea
01/2016 - 06/2011
3Merkel Cell Carcinoma
10/2023 - 01/2016
3Brain Neoplasms (Brain Tumor)
06/2019 - 06/2004
3Carcinoma (Carcinomatosis)
01/2016 - 11/2005
3Skin Diseases (Skin Disease)
09/2012 - 01/2006
3Lymphoma (Lymphomas)
11/2010 - 01/2007
2Eczema
08/2023 - 06/2023
2Erythema
06/2023 - 11/2002
2Infections
01/2022 - 01/2018
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2014 - 06/2010
2Pemphigus (Pemphigus Vulgaris)
03/2013 - 08/2007
2Bullous Pemphigoid (Pemphigoid)
07/2009 - 01/2002
2Mycosis Fungoides
06/2008 - 01/2007
2Body Weight (Weight, Body)
08/2007 - 01/2002
1Margins of Excision
11/2023
1Dysbiosis
09/2023
1Pigmentation Disorders (Ito Syndrome)
08/2023
1Facial Dermatoses
08/2023
1Rosacea (Acne Rosacea)
08/2023
1Panniculitis
04/2023
1Adult Acne
03/2022
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
03/2022
1Hyperandrogenism
03/2022

Drug/Important Bio-Agent (IBA)

15AntigensIBA
02/2021 - 03/2002
9IpilimumabIBA
10/2023 - 07/2015
8RetinoidsIBA
12/2023 - 06/2007
6trifaroteneIBA
01/2024 - 01/2021
6Immune Checkpoint InhibitorsIBA
09/2021 - 01/2017
6EpitopesIBA
01/2012 - 12/2003
5NivolumabIBA
10/2023 - 07/2015
5Anti-Bacterial Agents (Antibiotics)IBA
09/2023 - 01/2004
5VaccinesIBA
01/2022 - 12/2003
5VemurafenibIBA
06/2020 - 06/2011
5MART-1 AntigenIBA
12/2017 - 12/2003
5Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016 - 01/2002
5gluconic acid (gluconate)FDA LinkGeneric
09/2012 - 11/2002
5Peptides (Polypeptides)IBA
01/2012 - 12/2003
4Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2023 - 07/2012
4Isotretinoin (Accutane)FDA LinkGeneric
01/2022 - 07/2013
4HhAntag691IBA
01/2022 - 08/2014
4Monoclonal AntibodiesIBA
01/2021 - 11/2010
4InterferonsIBA
07/2015 - 12/2002
3Benzoyl PeroxideFDA LinkGeneric
06/2023 - 01/2004
3Adapalene (Differin)FDA LinkGeneric
06/2023 - 06/2007
3Dacarbazine (DIC)FDA LinkGeneric
04/2023 - 06/2011
3AntibodiesIBA
06/2019 - 01/2012
3Neoplasm Antigens (Tumor Antigens)IBA
01/2018 - 07/2003
3HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2018 - 03/2010
3Erythromycin (Erycette)FDA LinkGeneric
01/2017 - 01/2004
3Biomarkers (Surrogate Marker)IBA
10/2016 - 01/2016
3Rituximab (Mabthera)FDA Link
03/2013 - 08/2007
3Temozolomide (Temodar)FDA LinkGeneric
02/2013 - 06/2004
3ZincIBA
03/2010 - 01/2004
3Interleukin-2 (IL2)IBA
04/2007 - 03/2002
2Immunoglobulin A (IgA)IBA
12/2023 - 06/2023
2Niacinamide (Nicotinamide)FDA LinkGeneric
07/2023 - 04/2017
2CeramidesIBA
07/2023 - 06/2023
2Retinoic Acid Receptor gammaIBA
07/2022 - 01/2021
2Spironolactone (Aldactone)FDA LinkGeneric
03/2022 - 08/2017
2pembrolizumabIBA
09/2021 - 06/2020
2dabrafenibIBA
06/2020 - 09/2015
2trametinibIBA
06/2020 - 07/2012
2Cetuximab (Erbitux)FDA Link
10/2014 - 01/2012
2Proteins (Proteins, Gene)FDA Link
07/2013 - 03/2013
2TetracyclinesIBA
01/2012 - 05/2005
2Complementary DNA (cDNA)IBA
03/2010 - 10/2008
2HLA-B Antigens (HLA-B)IBA
02/2009 - 12/2003
2Monophenol Monooxygenase (Tyrosinase)IBA
02/2009 - 12/2003
2Prednisone (Sone)FDA LinkGeneric
08/2007 - 01/2002
2CytokinesIBA
06/2007 - 03/2002
2HLA-A*02:01 antigenIBA
10/2005 - 12/2003
2SaltsIBA
05/2005 - 01/2004
1CosmeceuticalsIBA
11/2023
1Vitamin A (Retinol)FDA LinkGeneric
07/2023
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
07/2023
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
07/2023
1AcidsIBA
01/2023
1Dehydroepiandrosterone SulfateIBA
03/2022
1AndrogensIBA
03/2022
1Progestins (Progestagens)IBA
03/2022
1Testosterone (Sustanon)FDA Link
03/2022
1Estrogens (Estrogen)FDA Link
03/2022

Therapy/Procedure

44Therapeutics
11/2023 - 01/2002
19Immunotherapy
11/2023 - 03/2002
8Drug Therapy (Chemotherapy)
11/2023 - 06/2004
7Radiotherapy
11/2023 - 06/2004
3Brachytherapy
03/2013 - 11/2005
2Skin Care
06/2023 - 01/2013
2Aftercare (After-Treatment)
07/2022 - 12/2017
1Adjuvant Radiotherapy
11/2023